- Trials with a EudraCT protocol (2,196)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,196 result(s) found for: Evaluation Research.
Displaying page 1 of 110.
EudraCT Number: 2014-005179-10 | Sponsor Protocol Number: ISS16694 | Start Date*: 2015-07-27 |
Sponsor Name:Charalampos Vlachopoulos | ||
Full Title: Effect of long-term testosterone replacement therapy on arterial stiffness and endothelial function in male patients with hypogonadism | ||
Medical condition: Male patients with hypogonadism | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004684-40 | Sponsor Protocol Number: N-O_CLI_Study | Start Date*: 2018-04-19 | |||||||||||
Sponsor Name:Krakowski Szpital Specjalistyczny im. Jana Pawła II | |||||||||||||
Full Title: Regeneration of ischemic damages in cardiovascular system using Wharton’s jelly as an unlimited source of mesenchymal stem cells for regenerative medicine. Project of the National Centre for Resear... | |||||||||||||
Medical condition: Critical limb ischemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000483-42 | Sponsor Protocol Number: 001 | Start Date*: 2016-05-19 |
Sponsor Name:ISPPCC - CHU Chrarleroi - Hôpital Civil Marie Curie - Clinique du Sein | ||
Full Title: Clinical, operating, prospective, academy, study of not inferiority of the Green Indocyanine (ICG) marking method, versus the radio-isotopic method, of sentinel nodes in breast. | ||
Medical condition: Axillar sentinel node research in Breast Cancer staging. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002726-32 | Sponsor Protocol Number: 65/2006/U/Sper | Start Date*: 2006-06-20 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in PCI | |||||||||||||
Medical condition: coronary angioplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005401-28 | Sponsor Protocol Number: AOI2021ME_PICKERING | Start Date*: 2022-01-26 |
Sponsor Name:University Hospital of Clermont-Ferrand | ||
Full Title: Effects of the combination of magnesium bisphosphonates versus bisphosphonates alone on bone remodeling: Randomized pilot clinical trial | ||
Medical condition: postmenopausal osteoporosis | ||
Disease: | ||
Population Age: Elderly | Gender: Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004343-12 | Sponsor Protocol Number: ICARISTrialProtocol | Start Date*: 2015-10-07 |
Sponsor Name:Mater Research Institute University of Queensland | ||
Full Title: Impact on Caesarean Section Rates Following Injections of Sterile Water | ||
Medical condition: Back pain in labour and childbirth | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003268-19 | Sponsor Protocol Number: BR-TUM-ICG-IV-2 | Start Date*: 2014-10-06 |
Sponsor Name:Jules Bordet Institute | ||
Full Title: Study evaluating breast cancer tumorectomy guided by Near-Infrared imaging after the intravenous injection of free Indocyanine Green | ||
Medical condition: Imaging of tumours and their margins after intravenous injection of Indocyanine Green to breast cancer patients | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003152-37 | Sponsor Protocol Number: MK3475-A18/ENGOT-cx11/GOG-3047 | Start Date*: 2020-05-28 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck &Co.,Inc | |||||||||||||
Full Title: A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer (KEYNOTE-A18 / ENGOT-cx11/GOG-3047) | |||||||||||||
Medical condition: High-risk locally advanced cervical cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NO (Ongoing) HU (Ongoing) CZ (Ongoing) ES (Ongoing) FR (Ongoing) IE (Ongoing) SE (Ongoing) DE (Ongoing) GR (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002565-34 | Sponsor Protocol Number: ERACLES01/2020 | Start Date*: 2021-03-10 | |||||||||||
Sponsor Name:SOCIETA' ITALIANA DI ENDOSCOPIA DIGESTIVA - SIED | |||||||||||||
Full Title: Evaluation of 2 different Regimens of colon preparation for an Advanced CLEaning using a 2lt peg-cs with simethicone: a randomized, controlled Study “ERACLES01/2020” | |||||||||||||
Medical condition: Intestinal cleaning in subjects submitted to colonscopy planned between 8:00 and 10.00 a.m.. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004984-11 | Sponsor Protocol Number: P150962J | Start Date*: 2018-07-06 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: "Study of maintenance of the efficacy and adverse effects of pharmacological treatments in sex offenders with paraphilia" ESPARA | |||||||||||||
Medical condition: Sexual offenders with paraphilia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017735-18 | Sponsor Protocol Number: UF8573 | Start Date*: 2010-05-28 |
Sponsor Name:CHRU Montpellier - Direction de la Recherche | ||
Full Title: Etude prospective, contrôlée, randomisée du traitement de l’occlusion sévère de la veine centrale de la rétine à sa phase précoce par injection intra-vitréenne de Bevacizumab | ||
Medical condition: retinal vein occlusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005361-12 | Sponsor Protocol Number: MELIBIO | Start Date*: 2013-03-07 |
Sponsor Name:HOPITAL SAINT JOSEPH | ||
Full Title: MEOPA (equimolar mixture of oxygen and protoxide of nitrogen) versus local anesthetic for analgesia during the biopsy of trophoblast. | ||
Medical condition: Pregnancy and biopsy of trophoblast | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003973-23 | Sponsor Protocol Number: 213831 | Start Date*: 2021-06-29 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd. | |||||||||||||
Full Title: A Randomized Phase 3 Double-Blinded Study Comparing the Efficacy and Safety of Niraparib to Placebo in Participants with Either HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Mole... | |||||||||||||
Medical condition: Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) IE (Ongoing) PL (Ongoing) NL (Ongoing) FI (Completed) BE (Ongoing) DE (Completed) IT (Prematurely Ended) ES (Ongoing) HU (Completed) PT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000622-67 | Sponsor Protocol Number: 3147K2-101WW | Start Date*: 2005-06-03 |
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc. | ||
Full Title: A Double-Blind, Placebo-Controlled, Randomized, Multiple Ascending Dose, Safety Study of MYO-029 Administered to Adult Patients with Becker, Facioscapulohumeral and Limb-Girdle Muscular Dystrophy. | ||
Medical condition: Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Limb-Girdle Muscular Dystrophy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-003461-35 | Sponsor Protocol Number: 20210096 | Start Date*: 2022-02-22 | ||||||||||||||||
Sponsor Name:Amgen Inc. | ||||||||||||||||||
Full Title: A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab plus Chemotherapy versus Placebo plus Chemotherapy in Subjects with Previously Untreated Advanced Gastric... | ||||||||||||||||||
Medical condition: Untreated Advanced Gastric or Gastroesophageal Junction Cancer with FGFR2b Overexpression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Trial now transitioned) LT (Trial now transitioned) LV (Ongoing) HU (Trial now transitioned) DK (Trial now transitioned) BE (Trial now transitioned) ES (Ongoing) IT (Ongoing) SE (Trial now transitioned) BG (Trial now transitioned) PT (Trial now transitioned) PL (Trial now transitioned) NO (Trial now transitioned) IE (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004109-15 | Sponsor Protocol Number: 1ABC | Start Date*: 2017-12-13 | |||||||||||
Sponsor Name:Medical University of Warsaw | |||||||||||||
Full Title: Evaluation of the safety and efficacy of the treatment of chronic wounds in diabetic foot syndrome with the use of autologous stem cells isolated from adipose tissue - within the project: "Therapeu... | |||||||||||||
Medical condition: Diabetic foot ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004843-22 | Sponsor Protocol Number: MK-7339-005 | Start Date*: 2020-02-04 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp. | |||||||||||||
Full Title: A Phase 3 Study of Pembrolizumab in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Part... | |||||||||||||
Medical condition: Extensive Stage Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) PL (Completed) ES (Prematurely Ended) FR (Prematurely Ended) BE (Completed) HU (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006453-27 | Sponsor Protocol Number: CNMPEPO 001 | Start Date*: 2007-02-01 | |||||||||||
Sponsor Name:Zdravstveni dom dr. Adolfa Drolca Maribor | |||||||||||||
Full Title: The use of epoetin beta in cardiac arrest victims: the impact on survival and neurological outcome | |||||||||||||
Medical condition: The aim of our prospective, randomized, multicentered and controlled research is to determine the impact of erythropoietin on survival and neurological outcome of cardiac arrest victims. On the bas... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019513-24 | Sponsor Protocol Number: 10_022 | Start Date*: 2011-03-03 |
Sponsor Name:London School of Hygiene & Tropical Medicine | ||
Full Title: Antibiotics for exacerbations of chronic obstructive pulmonary disease: a pilot randomised trial within the General Practice Research Database | ||
Medical condition: Diagnosed at a GP visit as suffering from acute exacerbation of COPD a. Medical history of COPD b. Increase in dyspnoea AND increase of (non-purulent) sputum volume | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001879-20 | Sponsor Protocol Number: 38RC18.085 | Start Date*: 2018-07-30 | |||||||||||
Sponsor Name:Grenoble Alps University Hospital | |||||||||||||
Full Title: Radiotherapy of multiple brain metastases using AGuIX® gadolinium-chelated polysiloxane based nanoparticles: a prospective randomized phase II clinical trial. | |||||||||||||
Medical condition: Patients with brain metastases, from a histologically confirmed solid tumor, eligible for WBRT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.